Table 3. Proposed classification for DNA sequence variants and correlation of clinical recommendation with probability that any given alteration is deleterious.
Class | Definition | Posterior Probability | Clinical Testing | Surveillance recommendations |
---|---|---|---|---|
5 | Definitely pathogenic | >0.99 | Test at-risk relatives for the variant | Full high-risk surveillance |
4 | Likely pathogenic | 0.95-0.99 | Test at-risk relatives for the variant | Full high-risk surveillance |
3 | Uncertain | 0.05-0.949 | Do not use as predictive testing in at-risk relatives | Counsel based on family history and other risk factors |
2 | Likely not pathogenic | 0.001-0.049 | Do not use as predictive testing in at-risk relatives | Counsel as if no mutation detected |
1 | Not Pathogenic | <0.001 | Do not use as predictive testing in at-risk relatives | Counsel as if no mutation detected |
Adapted from Plon et al., 2008.